h
Let’s Work Together
[email protected]

Meet Arrosa, the perfect theme to elevate your online presentation with.

Search here!
Eduardo Anitua_fondo

Eduardo Anitua

MD, DDS, PhD

Directeur de l’Institut Eduardo Anitua, Institut de recherche fondamentale et appliquée et Centre clinique et de formation en Implantologie orale et Thérapie régénérative. Directeur scientifique de BTI (Biotechnology Institute).

Licencié en Médecine et Chirurgie de l’Université de Salamanque en 1979 ; Docteur en médecine et chirurgie.

Spécialiste en Stomatologie de l’Université du Pays Basque, ayant poursuivi ses études lors de séjours aux États-Unis (Philadelphie, New York, Miami, San Francisco, Chicago) et en Europe (Italie, Allemagne, France, et bien entendu, Espagne).

Il a présenté des conférences dans différentes universités espagnoles et internationales, Troisième cycle sur les implants des universités de Séville, Murcie, Barcelone et Madrid.

Il a dispensé plus de 500 cours et conférences lors de congrès (en Europe, États-Unis, Amérique du Sud, Asie) sur les Implants, Prothèses, Esthétique Dentaire et Régénération tissulaire.

Directeur du programme de « Formation Continue en Implantologie et Réhabilitation Orale » dispensé en Espagne, au Mexique, Portugal, en Italie et Allemagne depuis 22 ans.

Professeur invité de la faculté d’odontologie des universités suivantes : Guatemala, Intercontinental de México, Javeriana de Colombie, République d’Argentine, Uruguay, Portugal (Faculté d’Oporto et Lisboa), Pennsylvanie, Harvard, Boston et Tufts.

Directeur de Dental Dialogue.

Cours enseignés

Articles publiés

Macrophages are innate immune cells that display remarkable phenotypic heterogeneity and functional plasticity. Due to their involvement in the pathogenesis of several human conditions, macrophages are considered to be an attractive therapeutic target. In line with this, platelet derivatives have been successfully applied in many medical fields and as active participants in innate immunity, cooperation between platelets and macrophages is essential. In this context, the aim of this review is to compile the current evidence regarding the effects of platelet derivatives on the phenotype and functions of macrophages to identify the advantages and shortcomings for feasible future clinical applications.

Wounds. 2024 Jun;36(6):189-200. Chronic skin ulceration is a serious pathological condition for which the adjuvant use of platelet-rich plasma (PRP) has been indicated. However, evidence for the use of PRP in patients with chronic skin ulcers remains insufficient due to a large heterogeneity in experimental designs, PRP composition, and preparation protocols.

There is a lack of consensus on managing resultant bone and soft tissue defects or on restoring oral function and aesthetics following medication-related osteonecrosis of the jaws (MRONJ) lesion healing. This clinical challenge presents a dilemma for practitioners. Removable prostheses pose a recurrence risk if poorly fitted and may inadequately restore function or aesthetics in cases of significant bone defect. Dental implant-supported prostheses could enhance function and quality of life, though their risks and indications are not well-defined. This systematic review examines the clinical outcomes and complications associated with implant-supported rehabilitations post-MRONJ surgery. This study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement recommendations and it was pre-registered in the Prospective Register of Systematic Reviews (PROSPERO) (CRD42023492539).

Dent J (Basel). 2024 Apr 24;12(5):122. The osteogenic differentiation process, by which bone marrow mesenchymal stem cells and osteoprogenitors transform into osteoblasts, is regulated by several growth factors, cytokines, and hormones. Plasma Rich in Growth Factors (PRGF) is a blood-derived preparation consisting of a plethora of bioactive molecules, also susceptible to containing epigenetic factors such as ncRNAs and EVs, that stimulates tissue regeneration. The aim of this study was to investigate the effect of the PRGF clot formulation on osteogenic differentiation. Firstly, osteoblast cells were isolated and characterised. The proliferation of bone cells cultured onto PRGF clots or treated with PRGF supernatant was determined.

  • Auteur:
  • Eduardo Anitua
  • Troya M
  • Zalduendo M
  • Tierno R
  • Alkhraisat MH
  • Osinalde N
  • Fullaondo A
  • Zubiaga AM

Biomed Pharmacother. 2024 May:174:116599. The aim of this study was to produce and characterize triple-layered cell sheet constructs with varying cell compositions combined or not with the fibrin membrane scaffold obtained by the technology of Plasma Rich in Growth Factors (mPRGF).

Vidéos disponibles sur BTI Channel

En plus de ce petit échantillon, sur BTI Channel, vous pouvez approfondir vos connaissances sur l’implantologie orale, la médecine régénérative et l’apnée du sommeil.

Eduardo Anitua
Implant unitaire extra-court
Eduardo Anitua
La biomécanique chez le patient édenté